http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005502690-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-243
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-525
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-502
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-663
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-282
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-243
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-525
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-683
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-502
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04
filingDate 2002-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2005-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2005502690-A
titleOfInvention Use of 4-pyridylmethylphthalazine for cancer treatment
abstract Kidney cancer patients are treated with 4-pyridylmethyl-phthalazine anti-angiogenic agents. Patients with different tumor types, such as kidney cancer, are treated with 4-pyridylmethyl-phthalazine anti-angiogenic agent with chemotherapy.
priorityDate 2001-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151194
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411548
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17972931
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135403648
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227140179
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408311
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227140178
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399412
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23149658
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135402009
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396070
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60953
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136123990
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226422204
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID643668
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399573
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399572
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57321499

Total number of triples: 46.